1.Murray BE: Beta-Lactamase-producing enterococci. Antimicrob Agents Chemother 1992;36: 2355-9. 2.Murray BE: Drug therapy: vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342: 710-21. 3.Leclercq R, Derlot E, Duval J, et al: Plasmidmediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-61. 4.Uttley AHC, Collins CH, Naidoo IA, et al: Vancomycin-resistant enterococci. Lancet 1988; 1:57-8. 5.Sahm DF, Kissinger J, Gilmore MS, et al: In vitro susceptibility studies of vancomycinresistant Enterococcus faecalis. Antimicrob Agents Chemother 1989; 1588-91. 6.Peng MY, Young TG, Yang CH, et al: Enterococcal bacteremia in a medical center. Chin Med J 1994; 54: 306-11. 7.Ben RJ, Lu JJ, Young TG, et al: Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan. J Formos Med Assoc 1996;95: 946-9. 8.Ho M, McDonald C, Lauderdale TL, et al: Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect 1999; 32:239-49 9.Centers for Disease Control and Prevention: Recommendations for preventing thespread of vancomycin resistance recommendations of the hospital infection control practices advisory committee (HICPAC). MMWR 1995; 44:1-13.